A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML
- Resource Type
- Article
- Authors
- Zeidan, Amer M. ; Boss, Isaac; Beach, C.L.; Copeland, Wilbert B.; Thompson, Ethan; Fox, Brian A.; Hasle, Vanessa E.; Hellmann, Andrzej; Taussig, David C.; Tormo, Mar; Voso, Maria Teresa; Cavenagh, James; O'Connor, Tim; Previtali, Alessandro; Rose, Shelonitda; Silverman, Lewis R.
- Source
- In Blood Advances 12 April 2022 6(7):2219-2229
- Subject
- Language
- ISSN
- 2473-9529